Thus it is not surprising that FRAT1 has been found to be strikingly overexpressed in several human cancers including esophageal cancer, cervical cancer, breast cancer, ovarian cancer, and non-small cell lung cancer [7], [10], [11], [12], [35]. This evidence concerns the gene FRAT1 and ovarian carcinoma.